Tamsulosin Hydrochloride
Product Images NDC 68071-2508

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 68071-2508). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2508 1)

This is a product label of Tamsulosin Hydrochloride 0.4 mg, a medication used for the treatment of an enlarged prostate in men. It comes in the form of 100 capsules per bottle from the manufacturer Care Pharmaceuticals, Inc. The label contains information such as the lot number, product number, expiration date, and serial number, to ensure safety during the distribution process. Additionally, there are warnings to keep the medication out of reach of children and to store it at a controlled temperature.*

FDA Label Image

Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-dose Administration Of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted And Fed Conditions (n=8) (Tamsulosin Fig1)

FDA Label Image

Figure 2a Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 1 (Tamsulosin Fig2)

This is a figure showing the mean change from baseline in Total AUA Symptom Score (0 to 35) for Study 1. The x-axis represents the duration of treatment in weeks, and the y-axis represents the mean change. The figure compares the treatment with -OO-0-08mg_~A= A -A04my_ O30 to placebo. There are different sample sizes for each duration of treatment, represented by n values.*

FDA Label Image

Figure 2b Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 2 (Tamsulosin Fig3)

This text appears to be a graph showing the Mean Change from Baseline in Total American Urological Association (AUA) Symptom Score for a study with three different treatments - O=0O—0-08mg, LNt 0.4mg and Placebo. The graph shows the duration of treatment in weeks and the number of participants in each treatment group. No further information is available.*

FDA Label Image

Figure 3a Mean Increase In Peak Urine Flow Rate (ml/sec) Study 1 (Tamsulosin Fig4)

This is a figure showing the mean increase in peak urine flow rate in L/sec in Study 1. The treatment group is divided into three categories: 0.08mg, 2x0.4mg, and placebo. The mean change in mL/sec is also shown on the graph along with the duration of treatment in weeks. Note: this figure does not include any insightful information without the appropriate context.*

FDA Label Image

Figure 3b Mean Increase In Peak Urine Flow Rate (ml/sec) Study 2 (Tamsulosin Fig5)

FDA Label Image

Chemical Structure (Tamsulosin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.